Detalhe da pesquisa
1.
Barriers and opportunities for gemcitabine in pancreatic cancer therapy.
Am J Physiol Cell Physiol
; 324(2): C540-C552, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571444
2.
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells.
Nat Cancer
; 3(11): 1386-1403, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411320
3.
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response.
Cancers (Basel)
; 13(11)2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34064221
4.
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer.
Cancers (Basel)
; 13(17)2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503069
5.
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration.
Adv Sci (Weinh)
; 8(14): 2100626, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34306986
6.
Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy.
Cells
; 9(9)2020 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948057
7.
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
United European Gastroenterol J
; 8(5): 594-606, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213029
8.
Immunotherapy: Pancreatic Cancer and Extrahepatic Biliary Tract Cancer.
Visc Med
; 35(1): 28-37, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31312647